Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Go back to Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results
(NASDAQ: PRAX) Delayed: 353.32 +1.51 (0.43%)
Previous Close $351.81    52 Week High
Open $342.25    52 Week Low
Day High $356.29    P/E N/A 
Day Low $339.50    EPS
Volume 181,810